Drawing for LAB FORWARD

USPTO serial 85918056

LAB FORWARD

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
TURNER, JASON FITZGERALD
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with LAB FORWARD?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Charles C. Wong

Charles C. Wong BECKMAN COULTER, INC.250 S. Kraemer Blvd.Brea, CA 92821UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Diagnostic reagents and assays and chemical preparations all for scientific, bioresearch, biomedical and laboratory research purposes and analysis; diagnostic reagents and assays and chemical preparations all for scientific and research purposes in the field of biotechnology; diagnostic chemicals and reagents for in vitro clinical and medical laboratory research use; antibody based chemicals and reagents for scientific and research use, namely, monoclonal antibodies; immunoassay test kits consisting primarily of in vitro reagents for the diagnosis and monitoring of conditions of physiological significance, all for laboratory research, biotechnology research, and bioresearch useACTIVE—
005Reagents for medical use; medical assays for testing of body fluids; chemical preparations, namely, chemical reagents for medical purposes; medical diagnostic reagents and assays for testing of body fluids; diagnostic preparations for medical purposes; diagnostic chemicals and diagnostic reagents for in vitro medical diagnostic use; diagnostic chemicals and diagnostic reagents for medical use; antibody-based chemicals and reagents for medical use, namely, monoclonal antibodies; diagnostic assay test kits for medical use consisting primarily of medical diagnostic chemicals and reagents; immunoassay test kits for medical use consisting primarily of in vitro reagents for the diagnosis and monitoring of physiological significance for medical purposesACTIVE—
009Instruments, systems, equipment and devices for laboratory research, biotechnology research, bioresearch, biomedical and non-medical clinical diagnosis research, namely, hematology and blood analyzers; automated microbiology analyzers for clinical research laboratory use; automated hematology chemistry analyzers for clinical research laboratory use; DNA analyzers for clinical research laboratory use; particle and cell size analyzers for scientific, laboratory research, and general research uses; gas absorption analyzers for scientific, laboratory research, and general research uses; scientific apparatus, namely, UV/visible spectrophotometers for scientific, laboratory research, and general research uses; scientific apparatus, namely, gamma scintillation counters and analyzers; pH meters for scientific research and laboratory use; liquid chromatography cell sorters for scientific laboratory use; laboratory equipment and supplies, namely, pipette tips, test tubes, test tube racks, centrifuge tube racks, and laboratory wetting traysACTIVE—
010Medical diagnostic devices, instruments and apparatus used in connection with patients for separating, detecting, analyzing, transporting, monitoring, and measuring materials in fluid and solid patient materials, namely, automated microbiology analyzers, automated hematology chemistry analyzers, DNA analyzers, particle and cell size analyzers, gas absorption analyzers, UV/visible spectrophotometers, gamma scintillation counters and analyzers, pH meters, liquid chromatography cell sorters, centrifuges and structural replacement parts therefor; instruments, systems and devices for medical diagnostic clinical analysis, namely, automated microbiology analyzers, automated hematology chemistry analyzers, DNA analyzers, particle and cell size analyzers, gas absorption analyzers, UV/visible spectrophotometers, gamma scintillation counters and analyzers, pH meters, liquid chromatography cell sorters, centrifugesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jun 15, 2015MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 15, 2015ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 3, 2015ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 3, 2015REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 12, 2014EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 10, 2014EX1GSOU EXTENSION 1 GRANTED—
Nov 10, 2014EXT1SOU EXTENSION 1 FILED—
Nov 10, 2014EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 13, 2014NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 18, 2014NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 18, 2014PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 26, 2014NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 7, 2014PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Feb 6, 2014CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 27, 2014TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 27, 2014CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 21, 2014ALIEASSIGNED TO LIE—
Jan 7, 2014TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 22, 2013GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 22, 2013GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 22, 2013CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 15, 2013DOCKASSIGNED TO EXAMINER—
May 6, 2013NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 2, 2013NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance